Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zai Lab (ZLAB) EBITDA (2020 - 2025)

Zai Lab's EBITDA history spans 6 years, with the latest figure at -$69.4 million for Q4 2025.

  • For Q4 2025, EBITDA fell 2.23% year-over-year to -$69.4 million; the TTM value through Dec 2025 reached -$229.4 million, up 18.67%, while the annual FY2025 figure was -$229.4 million, 18.67% up from the prior year.
  • EBITDA for Q4 2025 was -$69.4 million at Zai Lab, down from -$48.8 million in the prior quarter.
  • Across five years, EBITDA topped out at -$48.8 million in Q3 2025 and bottomed at -$227.1 million in Q1 2021.
  • The 5-year median for EBITDA is -$81.5 million (2021), against an average of -$99.1 million.
  • The largest annual shift saw EBITDA tumbled 390.25% in 2021 before it soared 64.88% in 2022.
  • A 5-year view of EBITDA shows it stood at -$219.2 million in 2021, then skyrocketed by 55.61% to -$97.3 million in 2022, then dropped by 27.43% to -$124.0 million in 2023, then soared by 45.24% to -$67.9 million in 2024, then decreased by 2.23% to -$69.4 million in 2025.
  • Per Business Quant, the three most recent readings for ZLAB's EBITDA are -$69.4 million (Q4 2025), -$48.8 million (Q3 2025), and -$54.9 million (Q2 2025).